Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026

Rhea-AI Summary

Balchem (NASDAQ: BCPC) will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Senior management attendees include Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director, Investor Relations).

The company will present and engage with investors at the industry conference, offering updates on strategy and market positioning for health and nutrition ingredients.

Key Figures

Conference date: March 10, 2026

1 metrics

Conference date March 10, 2026 JP Morgan Consumer Ingredients Forum participation

Market Reality Check

Price: $175.74 Vol: Volume 165,398 is essenti...

normal vol

$175.74 Last Close

Volume Volume 165,398 is essentially in line with the 20-day average of 167,564, suggesting no unusual trading ahead of this conference update. normal

Technical BCPC trades above its 200-day MA of 159.10 with a price of 175.74, and sits about 3.97% below its 52-week high of 183.01.

Peers on Argus

BCPC gained 2.56% while key peers showed mixed moves: SXT +2.37%, ESI +3.58%, SS...

2 Up

BCPC gained 2.56% while key peers showed mixed moves: SXT +2.37%, ESI +3.58%, SSL +0.92%, CBT -0.56%, AXTA -0.80%. With only two peers in the momentum scan and mixed directions overall, today’s action appears more stock-specific than a broad specialty chemicals move.

Historical Context

5 past events · Latest: Feb 20 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 20	Earnings results	Positive	-3.6%	Record 2025 sales, EBITDA and free cash flow with higher EPS and dividend.
Feb 06	Earnings call setup	Neutral	-0.3%	Announcement of Q4 and full-year 2025 earnings call and webcast details.
Jan 02	Conference participation	Neutral	+0.4%	Participation in CJS virtual conference to discuss strategy with investors.
Dec 22	Regulatory update	Positive	+0.5%	EU anti-dumping duties on Chinese choline chloride supporting EU producers.
Dec 10	Dividend increase	Positive	+2.4%	Annual dividend raised 10.3%, seventeenth consecutive yearly increase.

Pattern Detected

Recent history shows generally positive reactions to capital return and regulatory wins, while strong earnings in Feb 2026 saw a short-term pullback despite record results.

Recent Company History

Over the past few months, Balchem reported record 2025 sales and earnings, raised its dividend for a seventeenth consecutive year, and highlighted supportive EU anti-dumping measures on choline chloride. It also maintained an active investor-relations schedule with conferences and earnings calls. Against that backdrop, this JP Morgan forum appearance continues a pattern of regular engagement with investors rather than marking a new fundamental development.

Market Pulse Summary

This announcement highlights Balchem’s continued engagement with the investment community via the JP...

Analysis

This announcement highlights Balchem’s continued engagement with the investment community via the JP Morgan Consumer Ingredients Forum on March 10, 2026. It follows record 2025 financial results, dividend growth, and supportive EU trade measures, reinforcing an established communication cadence. Investors may focus more on what management chooses to emphasize at the event—growth priorities, capital deployment, and segment performance—than on the conference participation itself.

AI-generated analysis. Not financial advice.

MONTVALE, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:         Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)

FAQ

When will Balchem (BCPC) present at the JP Morgan Consumer Ingredients Forum in 2026?

Balchem will participate on March 10, 2026 at the JP Morgan forum. According to the company, senior management including the CEO and CFO will attend and engage with investors and industry participants during the event.

Which Balchem (BCPC) executives will attend the March 10, 2026 JP Morgan Consumer Ingredients Forum?

Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director, Investor Relations) will attend. According to the company, these executives will represent Balchem in investor meetings and conference sessions.

How can investors access Balchem (BCPC) updates from the March 10, 2026 JP Morgan forum?

Investors can expect company presentations and investor meetings during the March 10 event. According to the company, webcast links or investor relations materials may be posted on Balchem's investor relations site after the conference.

What topics will Balchem (BCPC) likely address at the March 10, 2026 JP Morgan Consumer Ingredients Forum?

Balchem is expected to discuss strategy, product offerings, and market positioning in health and nutrition ingredients. According to the company, senior leaders will meet investors and provide business updates relevant to industry trends and performance.

Does Balchem (BCPC) often participate in investor conferences like the JP Morgan Consumer Ingredients Forum?

Balchem regularly engages in investor conferences to communicate strategy and performance to stakeholders. According to the company, participation allows senior management to meet investors, present updates, and discuss industry developments at events like the March 10 forum.